News | News By Subject | News by Disease News By Date | Search News

Obesity News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
SoCal Biotech Arena (ARNA) Officially Bails on Weight Loss Drug to Focus on New Products     1/5/2017
Zafgen (ZFGN) Pinks Slips 34% of Workforce, Scraps Lead Obesity Drug After Deaths     7/21/2016
Citius Pharma Discontinues Development of Weight Loss Drug Suprenza     7/5/2016
Takeda (TKPYY) Sells U.S. Rights to Contrave Back to Orexigen (OREX), Establishes New Business Units     3/15/2016
Zafgen (ZFGN) Surges as Obesity Drug Succeeds in Phase IIb Trial     2/18/2016
Zafgen (ZFGN) Falls as Hedge Fund Shorts Stock, Claims Obesity Drug Will Not Gain FDA Approval     1/25/2016
Rhythm Wins FDA Breakthrough Tag for Setmelanotide for the Treatment Of POMC Deficiency Obesity     1/7/2016
Zafgen (ZFGN) Plunges Some More After FDA Orders Full Clinical Hold on Beloranib     12/3/2015
Zafgen (ZFGN) Plagued By More Bad News as Second Patient Dies in Obesity Drug Trial     12/2/2015
Johnson & Johnson (JNJ) Unit, Hanmi Pharma Ink Diabetes and Obesity Pact Worth $915 Million     11/9/2015
Embattled Zafgen (ZFGN) Continues Obesity Clinical Trials Despite Patient Death and Pending Class Action Lawsuit     10/22/2015
GlaxoSmithKline (GSK), University of California, Los Angeles (UCLA) Researchers Will Work Together on New Collaborative R&D Model     10/20/2015
After Patient Death in Zafgen (ZFGN)'s Phase III Obesity Study, FDA Places Partial Hold on Trial     10/16/2015
Emisphere (EMIS), Novo Nordisk A/S (NVO) Ink $221 Million+ Deal Develop Oral Formulations of Four Molecules Targeting Metabolic Indications     10/15/2015
Symmetry Medical (SMA) Scores $30K Crowdfunding Goal to Support Anti-Obesity Compound     10/14/2015

News from Around the Web
What’s Weighing Down The Billion-Dollar Obesity Drug Market?     5/9/2017
Obesity And 4 Other Conditions Lead Americans To The Grave, Cleveland Clinic Study     4/28/2017
Could A Worm Gene Be The Key To Conquering Obesity? Monash University Study     2/14/2017
Stephen Hawking Is Right But Also Wrong About Obesity     12/5/2016
Soda Taxes Are On Four City Ballots — Will They Make A Dent In Obesity?     11/8/2016
King's College London Scientists Find New Fat Clues In Feces     9/27/2016
Can Marijuana Really Reduce Pot Bellies And Obesity? Yale Study     9/20/2016
An Animal Biologist Has A Special Diet Plan For Mice     9/19/2016
Do You Overeat? Blame Childhood Stress, Texas Christian University Study     9/2/2016
Excess Weight Linked To 8 More Cancers, Washington University School of Medicine Reveals     8/31/2016
Researchers Target Gut Bacteria To Reduce Weight Gain, Vanderbilt University Study     8/29/2016
How Fish Oil Pills Can Reverse The Effects Of A Fatty Diet, University of Sao Paulo Study     8/25/2016
How Much A Decade Of Obesity Raises Your Cancer Risk, WHO Reveals     8/17/2016
Half Of Women Overweight Before Getting Pregnant, CDC Study     8/9/2016
Your Weight Could Make The Flu Shot Less Effective, WHO Reveals     8/8/2016

Press Releases
GI Dynamics (GID.AX) Release: Meta-Analysis Show Endobarrier Improves Glycemic Control, Induces Weight Loss In Patients With Type 2 Diabetes And Obesity     5/23/2017
Novo Nordisk A/S (NVO) Release: Early Response To Saxenda Resulted In Weight Maintenance And Additional Weight Loss Over 56 Week     5/17/2017
Rhythm Expands Phase II Clinical Trials Of Setmelanotide To The Treatment Of Bardet-Biedl Syndrome Obesity     5/17/2017
NxThera Release: Data Presented Shows Minimally Invasive Rezum System Provides Significant LUTS Relief In Obese Men While Preserving Sexual Function     5/16/2017
Cutera (CUTR) Launches truSculpt 3D … A New Dimension In Body Sculpting     5/16/2017
Rhythm Receives Expanded FDA Breakthrough Therapy Designation For Setmelanotide For Rare Genetic Disorders Of Obesity     5/11/2017
Zealand Pharma  (ZEAL.CO) Discloses Amylin As The Biological Target Under Their 2014 Agreement With Boehringer Ingelheim     5/11/2017
Obalon Receives Regulatory Approvals To Commercialize In Select Middle East Markets     5/11/2017
Struggling Zafgen (ZFGN) Catches A Break With Promising Early-Stage Obesity Data     5/5/2017
Rhythm Starts Phase III Clinical Trial Of Setmelanotide For Rare Genetic Disorder Of Obesity     5/4/2017
ProMetic Life Sci (PFSCF.PK)'s PBI-4050 Shown To Reduce Liver Damage And Fibrosis In High-Fat Diet Induced Obesity And Metabolic Syndrome Mouse Model     4/20/2017
Saniona's Partner, Medix, Obtains Approval To Initiate Phase III Study In Obesity     4/12/2017
Neothetics (NEOT) Announces Last Subject Enrolled In Phase II Proof Of Concept Trial For LIPO-202 For The Reduction Of Submental Subcutaneous Fat     3/20/2017
GI Dynamics (GID.AX) Shows Off Prelim Endobarrier Data in Adolescent Prediabetes Treatment     2/17/2017
EnteroMedics (ETRM) Announces Publication Of Three-Year Data From vBloc Diabetic Patient Study In Journal Of Diabetes And Obesity     2/9/2017

//-->